COMMUNIQUÉS West-GlobeNewswire

Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO
28/02/2024
Press Release Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO More than 25 years of experience in senior business development and corporate roles, with over 6 years as Chief Business Officer of Nicox [...]
Gavin Spencer, dirigeant expérimenté du secteur de la biotechnologie, nommé Directeur Général de Nicox
28/02/2024
Communiqué de presse Gavin Spencer, dirigeant expérimenté du secteur de la biotechnologie, nommé Directeur Général de Nicox Plus de 25 ans d'expérience dans des fonctions stratégiques et de Business Development de [...]
Nicox Restructures Debt, Streamlines Operations to Extend Cash Runway and Focus Resources on NCX 470 Pivotal Trial
28/02/2024
Press Release Nicox Restructures Debt, Streamlines Operations to Extend Cash Runway and Focus Resources on NCX 470 Pivotal Trial Agreement in principle for an amendment to debt agreements for outstanding bonds [...]
Nicox restructure sa dette et réduit sa structure pour étendre son horizon de trésorerie et prioriser les ressources sur l’étude pivotale sur le NCX 470
28/02/2024
Communiqué de presse Nicox restructure sa dette et réduit sa structure pour étendre son horizon de trésorerie et prioriser les ressources sur l’étude pivotale sur le NCX 470 Signature d'un accord de principe pour [...]
ObsEva Announces Wind-Down of Operations and Notifies SIX that it Will Lack the Resources to Establish Audited IFRS Financial Statements for 2023
28/02/2024
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – 28 February 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women's health, today [...]
Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)
28/02/2024
February 28, 2024 Proposal to appoint Ms. Hanneman as member of Philips’ Board of Management fulfilling the role of CFO per October 1, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global [...]
Strong data from DSR® proof-of-concept studies in heart failure accepted for late-breaking presentation at THT 2024
28/02/2024
Presentation by Key Opinion Leader Dr. Testani on Wednesday, March 6 th 2024 Ghent, Belgium – 28 February 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the [...]
Idorsia and Viatris enter into a significant global research and development collaboration
28/02/2024
Ad hoc announcement pursuant to Art. 53 LR Viatris and Idorsia will collaborate on the global development and commercialization of two Phase 3 assets, selatogrel and cenerimod. Idorsia to receive an upfront payment of [...]
Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
28/02/2024
MIAMI, FL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for higher quality weight loss, [...]
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
27/02/2024
ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the [...]
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
27/02/2024
QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-driven drug discovery // AI-driven insights complement human-curated [...]
Sotera Health Announces Secondary Offering of Common Stock
27/02/2024
CLEVELAND, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share [...]
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
27/02/2024
HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2023 before the market opens on March 7, 2024, and will [...]
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
27/02/2024
LOWELL, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate [...]
Ultragenyx to Participate at Investor Conferences in March
27/02/2024
44 th Annual Cowen Healthcare Conference on March 4 Leerink Partners Global Biopharma Conference on March 12 Barclays 26 th Annual Global Healthcare Conference on March 13 NOVATO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE [...]
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
27/02/2024
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
27/02/2024
Fourth quarter 2023 net sales of Qelbree ® increased 97% to $46.4 million compared to fourth quarter 2022; Full year 2023 net sales of Qelbree increased 129% to $140.2 million compared to full year 2022. Fourth quarter [...]
LeMaitre Q4 2023 Financial Results
27/02/2024
BURLINGTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2023 results, announced a $0.16/share quarterly dividend and provided [...]
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
27/02/2024
Multiple clinical programs from Recursion’s first generation platform are on track to read out Phase 2 data in H2 2024 and H1 2025 with additional second generation programs approaching IND in the near-term In-licensed [...]

Pages